160059 A human rights approach to law and decision-making on trade and access to essential medicines: A critical perspective

Tuesday, November 6, 2007: 8:50 AM

Clancy J. Kelly, BA GDip MIC Law , Law School, University of Melbourne, Carlton, Melbourne, Australia
A human rights approach to standards and decision-making processes on trade and access to essential medicines issues at the national and international levels, draws on all sources of international human rights law and policy. The elements of inclusiveness, participation, transparency and accountability are particularly relevant to a human rights approach to decision-making, while the right to access to essential medicines, as a “floor” right, and with respect to equity, are the relevant human rights legal standards. The application of these criteria is particularly relevant nationally to the United States, and internationally, to the World Health Organization and the World Trade Organization. The US is particularly relevant in this context because of the Government's refusal to recognize the right to health, the influence of major pharmaceutical corporations on US health and trade law and policies, and the influence of the US on international trade and health law and policies. The World Health Organization and the World Trade Organization are particularly relevant because they are the leading international public health and trade bodies respectively, with a growing body of evidence of unfair and inequitable decision-making processes resulting in laws and policies that are not consistent with international human rights standards. The development of a human rights approach to trade and health is greatly facilitated by a discourse between human rights and health professionals on these issues. Public health professionals working at all levels are therefore in a better position to promote fair and equitable decision-making and the right to essential medicines.

Learning Objectives:
1. Participants will gain information on a human rights approach to trade and essential medicines policies, and fair and equitable decision-making. 2. Participants will then be able to apply this approach to the actual decision-making processes and standards on these issues, at the national level (with a focus on the United States) and the international level, with a focus on the World Health Organization and the World Trade Organization. 3.Through the application of these standards to their own work, participants will able to develop strategies for the promotion of fair and equitable decision-making, and standards that are consistent with the international right to health.

Keywords: Medicine, Equal Access

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.